跳至主要内容
临床试验/TCTR20200311001
TCTR20200311001已完成3 期

Comparison lactate clearance between high dose and conventional dose of Meropenem in sepsis patients Emergency Department; Post-HOC analysis of a randomized controlled trial

Ramathibodi hospital Mahidol university0 个研究点目标入组 43 人开始时间: 2020年3月11日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 110 Years(—)
性别
All

入选标准

  • 1) patients aged ≥ 18 years
  • 2) patients who diagnosed as sepsis and septic shock according to sepsis-3 criteria
  • 3) patients were receiving Meropenem as empirical eligible for enrollment

排除标准

  • 1) patients receiving Meropenem within 7 day before enrollment, 2) patients requiring operations within 72 hours after enrollment 3) patients having known allergy or had contraindication to Meropenem 4) patients who receiving Extracorporeal membrane oxygenation 5) patients who having sepsis with central nervous system infection, infective endocarditis or osteomyelitis, 6) patients with active seizure or status epilepticus 7) patients who receiving cardiopulmonary resuscitation before enrollment

研究者

发起方
Ramathibodi hospital Mahidol university

相似试验